Luc Morris/mskcc.org
Jan 15, 2025, 16:42
New AI Tool Predicts Immunotherapy Response Using Blood Tests – Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center shared a post on X:
“A new AI-based tool, developed by a team of researchers from MSK and The Tisch Cancer Institute, could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors – a type of immunotherapy – using only routine blood tests and clinical data.
Learn more about how this effort could make the treatment more accessible around the globe.”
More posts featuring Memorial Sloan Kettering Cancer Center.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 23, 2025, 17:10
Apr 23, 2025, 16:51
Apr 23, 2025, 16:12
Apr 23, 2025, 16:07